Patricia Flynn

TitleAdjunct Faculty
InstitutionThomas Jefferson University
DepartmentNursing - Graduate
Address130 S. 9th Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Agwu AL, Flynn PM. Increasing the urgency to identify adolescents and young adults with HIV infection…do or die. AIDS. 2021 03 15; 35(4):693-695. PMID: 33620875.
      Citations:    
    2. Patel ND, Dallas RH, Knapp KM, Flynn PM, Gaur AH. Rapid Start of Antiretroviral Therapy in Youth Diagnosed with HIV Infection. Pediatr Infect Dis J. 2021 Feb 01; 40(2):147-150. PMID: 33399434.
      Citations:    
    3. Gaur AH, McCarthy JS, Panetta JC, Dallas RH, Woodford J, Tang L, Smith AM, Stewart TB, Branum KC, Freeman BB, Patel ND, John E, Chalon S, Ost S, Heine RN, Richardson JL, Christensen R, Flynn PM, Van Gessel Y, Mitasev B, Möhrle JJ, Gusovsky F, Bebrevska L, Guy RK. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Lancet Infect Dis. 2020 Apr 07. PMID: 32275867.
      Citations:    
    4. Angelidou K, Fowler MG, Flynn P, Coletti A, McCarthy K, Browning R, McIntyre J, Brummel SS, Shapiro DE, Tierney C. Enrollment and transition challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) network's PROMISE trial for resource-limited regions. Clin Trials. 2020 Mar 19; 1740774520912428. PMID: 32191142.
      Citations:    
    5. Aizire J, Brooks KM, Mirochnick M, Flynn PM, Butler K, Kiser JJ, Siberry GK, Fenton T, Cababasay M, Fowler MG. Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial. J Acquir Immune Defic Syndr. 2020 Feb 01; 83(2):173-180. PMID: 31929405.
      Citations:    
    6. Flynn PM, Betancourt H, Emerson ND, Nunez EI, Nance CM. Health professional cultural competence reduces the psychological and behavioral impact of negative healthcare encounters. Cultur Divers Ethnic Minor Psychol. 2020 Jul; 26(3):271-279. PMID: 31697099.
      Citations:    
    7. Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019 08 01; 33(10):1657-1662. PMID: 31021852.
      Citations:    
    8. Flynn PM, Abrams EJ. Response to correspondence entitled: Perinatal HIV and response to vaccination. AIDS. 2019 Aug 01; 33(10):1675-1677. PMID: 31305335.
      Citations:    
    9. Le CN, Britto P, Brummel SS, Hoffman RM, Li JZ, Flynn PM, Taha TE, Coletti A, Fowler MG, Bosch RJ, Gandhi RT, Klingman KL, Mcintyre JA, Currier JS. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared to men. AIDS. 2019 Aug 01. PMID: 31373919.
      Citations:    
    10. Amico KR, Dunlap A, Dallas R, Lindsey J, Heckman B, Flynn P, Lee S, Horvath K, West Goolsby R, Hudgens M, Filipowicz T, Polier M, Hill E, Mueller Johnson M, Miller J, Neilan A, Ciaranello A, Gaur A. Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention. JMIR Res Protoc. 2019 Mar 18; 8(3):e11416. PMID: 30882360.
      Citations:    
    11. Daniels CC, Burlison JD, Baker DK, Robertson J, Sablauer A, Flynn PM, Campbell PK, Hoffman JM. Optimizing Drug-Drug Interaction Alerts Using a Multidimensional Approach. Pediatrics. 2019 Feb 13. PMID: 30760508.
      Citations:    
    12. Wolf J, Connell TG, Curtis N, Flynn PM. Ethanol lock therapy. Lancet Infect Dis. 2018 Dec; 18(12):1306. PMID: 30507448.
      Citations:    
    13. Flynn PM, Abrams EJ. Growing up with perinatal HIV. AIDS. 2018 Nov 27. PMID: 30531318.
      Citations:    
    14. Lyon ME, Garvie PA, D'Angelo LJ, Dallas RH, Briggs L, Flynn PM, Garcia A, Cheng YI, Wang J. Advance Care Planning and HIV Symptoms in Adolescence. Pediatrics. 2018 Oct 19. PMID: 30341154.
      Citations:    
    15. Wolf J, Connell TG, Allison KJ, Tang L, Richardson J, Branum K, Borello E, Rubnitz JE, Gaur AH, Hakim H, Su Y, Federico SM, Mechinaud F, Hayden RT, Monagle P, Worth LJ, Curtis N, Flynn PM. Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial. Lancet Infect Dis. 2018 Jun 05. PMID: 29884572.
      Citations:    
    16. Turkova A, Moore CL, Butler K, Compagnucci A, Saïdi Y, Musiime V, Nanduudu A, Kaudha E, Cressey TR, Chalermpantmetagul S, Scott K, Harper L, Montero S, Riault Y, Bunupuradah T, Volokha A, Flynn PM, Bologna R, Ramos Amador JT, Welch SB, Nastouli E, Klein N, Giaquinto C, Ford D, Babiker A, Gibb DM. Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial. PLoS One. 2018; 13(4):e0196239. PMID: 29684092.
      Citations:    
    17. Flynn PM. A broader look at adolescents with perinatal HIV. Nature. 2018 04; 556(7702):439-440. PMID: 29686368.
      Citations:    
    18. Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanashanmugam D, Chakhtoura N, McCarthy K, Mukuzunga C, Makanani B, Moodley D, Nematadzira T, Kusakara B, Patil S, Vhembo T, Bobat R, Mmbaga BT, Masenya M, Nyati M, Theron G, Mulenga H, Butler K, Shapiro DE. Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial. J Acquir Immune Defic Syndr. 2018 Apr 01; 77(4):383-392. PMID: 29239901.
      Citations:    
    19. Arenas-Pinto A, Grund B, Sharma S, Martinez E, Cummins N, Fox J, Klingman KL, Sedlacek D, Collins S, Flynn PM, Chasanov WM, Kedem E, Katlama C, Sierra-Madero J, Afonso C, Brouwers P, Cooper DA. Risk of Suicidal Behavior With Use of Efavirenz: Results from the Strategic Timing of Antiretroviral Treatment Trial. Clin Infect Dis. 2018 Mar 12. PMID: 29538636.
      Citations:    
    20. Fowler MG, Flynn P, Aizire J. What is new in perinatal HIV prevention? Curr Opin Pediatr. 2018 02; 30(1):144-151. PMID: 29315112.
      Citations:    
    21. Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clin Infect Dis. 2018 Jan 06; 66(2):220-228. PMID: 29020329.
      Citations:    
    22. Wolf J, Tang L, Flynn PM, Pui CH, Gaur AH, Sun Y, Inaba H, Stewart T, Hayden RT, Hakim H, Jeha S. Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia. Clin Infect Dis. 2017 Nov 13; 65(11):1790-1798. PMID: 29020310.
      Citations:    
    23. Lyon ME, D'Angelo LJ, Dallas RH, Hinds PS, Garvie PA, Wilkins ML, Garcia A, Briggs L, Flynn PM, Rana SR, Cheng YI, Wang J. A randomized clinical trial of adolescents with HIV/AIDS: pediatric advance care planning. AIDS Care. 2017 Oct; 29(10):1287-1296. PMID: 28359212.
      Citations:    
    24. Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N, Wilson CM, Hazra R, Hosek SG, Anderson PL, Seifert SM, Kapogiannis BG, Mulligan K. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clin Infect Dis. 2017 Feb 01; 64(3):317-325. PMID: 28013265.
      Citations:    
    25. Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016 11 03; 375(18):1726-1737. PMID: 27806243.
      Citations:    
    26. Lombaard J, Bunupuradah T, Flynn PM, Ramapuram J, Ssali F, Crauwels H, Hoogstoel A, Van Eygen V, Stevens M. Rilpivirine as a Treatment for HIV-infected Antiretroviral-naïve Adolescents: Week 48 Safety, Efficacy, Virology and Pharmacokinetics. Pediatr Infect Dis J. 2016 Nov; 35(11):1215-1221. PMID: 27294305.
      Citations:    
    27. Hakim H, Allison KJ, Van de Velde LA, Tang L, Sun Y, Flynn PM, McCullers JA. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection. Vaccine. 2016 06 08; 34(27):3141-3148. PMID: 27129426; PMCID: PMC4899146.
      Citations:    
    28. Kapogiannis BG, Leister E, Siberry GK, Van Dyke RB, Rudy B, Flynn P, Williams PL. Prevalence of and progression to abnormal noninvasive markers of liver disease (aspartate aminotransferase-to-platelet ratio index and Fibrosis-4) among US HIV-infected youth. AIDS. 2016 Mar 27; 30(6):889-98. PMID: 26959353.
      Citations:    
    29. Shenep MA, Tanner MR, Sun Y, Culley T, Hayden RT, Flynn PM, Tang L, Wolf J. Catheter-Related Complications in Children With Cancer Receiving Parenteral Nutrition: Change in Risk Is Moderated by Catheter Type. JPEN J Parenter Enteral Nutr. 2017 Aug; 41(6):1063-1071. PMID: 26743773.
      Citations:    
    30. Hakim H, Dallas R, Zhou Y, Pei D, Cheng C, Flynn PM, Pui CH, Jeha S. Acute respiratory infections in children and adolescents with acute lymphoblastic leukemia. Cancer. 2016 Mar 01; 122(5):798-805. PMID: 26700662; PMCID: PMC4764417.
      Citations:    
    31. Herbozo S, Flynn PM, Stevens SD, Betancourt H. Dietary Adherence, Glycemic Control, and Psychological Factors Associated with Binge Eating Among Indigenous and Non-Indigenous Chileans with Type 2 Diabetes. Int J Behav Med. 2015 Dec; 22(6):792-8. PMID: 25786595.
      Citations:    
    32. Sealy RE, Jones BG, Surman SL, Branum K, Howlett NM, Flynn PM, Hurwitz JL. Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins. Viral Immunol. 2016 Jan-Feb; 29(1):64-70. PMID: 26544795; PMCID: PMC4717494.
      Citations:    
    33. Wolf J, Tang L, Rubnitz JE, Brennan RC, Shook DR, Stokes DC, Monagle P, Curtis N, Worth LJ, Allison K, Sun Y, Flynn PM. Monitoring Central Venous Catheter Resistance to Predict Imminent Occlusion: A Prospective Pilot Study. PLoS One. 2015; 10(8):e0135904. PMID: 26322512; PMCID: PMC4555832.
      Citations:    
    34. Ojha RP, Stallings-Smith S, Flynn PM, Adderson EE, Offutt-Powell TN, Gaur AH. The Impact of Vaccine Concerns on Racial/Ethnic Disparities in Influenza Vaccine Uptake Among Health Care Workers. Am J Public Health. 2015 Sep; 105(9):e35-41. PMID: 26180953.
      Citations:    
    35. Amador JA, Flynn PM, Betancourt H. Cultural beliefs about health professionals and perceived empathy influence continuity of cancer screening following a negative encounter. J Behav Med. 2015 Oct; 38(5):798-808. PMID: 26032574.
      Citations:    
    36. Curtis DJ, Muresan P, Nachman S, Fenton T, Richardson KM, Dominguez T, Flynn PM, Spector SA, Cunningham CK, Bloom A, Weinberg A. Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth. PLoS One. 2015; 10(3):e0118567. PMID: 25785995; PMCID: PMC4364897.
      Citations:    
    37. Flynn PM, Betancourt H, Garberoglio C, Regts GJ, Kinworthy KM, Northington DJ. Attributions and emotions regarding health care mistreatment impact continuity of care among Latino and Anglo American women. Cultur Divers Ethnic Minor Psychol. 2015 Oct; 21(4):593-603. PMID: 25602469.
      Citations:    
    38. Flynn P, Komar S, Blanche S, Giaquinto C, Noguera-Julian A, Welch S, Lathouwers E, Van de Casteele T, Kakuda TN, Opsomer M. Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE). Pediatr Infect Dis J. 2014 Sep; 33(9):940-5. PMID: 25361024.
      Citations:    
    39. Wolf J, Allison KJ, Tang L, Sun Y, Hayden RT, Flynn PM. No evidence of benefit from antibiotic lock therapy in pediatric oncology patients with central line-related bloodstream infection: results of a retrospective matched cohort study and review of the literature. Pediatr Blood Cancer. 2014 Oct; 61(10):1811-5. PMID: 24923808.
      Citations:    
    40. Hicks JK, Crews KR, Flynn P, Haidar CE, Daniels CC, Yang W, Panetta JC, Pei D, Scott JR, Molinelli AR, Broeckel U, Bhojwani D, Evans WE, Relling MV. Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics. 2014 Jun; 15(8):1065-78. PMID: 25084200; PMCID: PMC4155516.
      Citations:    
    41. Carter R, Wolf J, van Opijnen T, Muller M, Obert C, Burnham C, Mann B, Li Y, Hayden RT, Pestina T, Persons D, Camilli A, Flynn PM, Tuomanen EI, Rosch JW. Genomic analyses of pneumococci from children with sickle cell disease expose host-specific bacterial adaptations and deficits in current interventions. Cell Host Microbe. 2014 May 14; 15(5):587-599. PMID: 24832453; PMCID: PMC4066559.
      Citations:    
    42. Apiwattankul N, Flynn PM, Hayden RT, Adderson EE. Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer. J Pediatric Infect Dis Soc. 2015 Jun; 4(2):104-13. PMID: 26407409; PMCID: PMC4608491.
      Citations:    
    43. Inaba H, Gaur AH, Cao X, Flynn PM, Pounds SB, Avutu V, Marszal LN, Howard SC, Pui CH, Ribeiro RC, Hayden RT, Rubnitz JE. Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia. Cancer. 2014 Jul 01; 120(13):1985-92. PMID: 24677028; PMCID: PMC4063871.
      Citations:    
    44. Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K. Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate. Antivir Ther. 2014; 19(6):613-8. PMID: 24535626; PMCID: PMC4135028.
      Citations:    
    45. Maron GM, Hayden RT, Rodriguez A, Rubnitz JE, Flynn PM, Shenep JL, Knapp KM. Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections. Pediatr Infect Dis J. 2013 Dec; 32(12):e451-5. PMID: 23907262.
      Citations:    
    46. Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL, Tang J. Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein. Front Genet. 2013; 4:234. PMID: 24294218; PMCID: PMC3827582.
      Citations:    
    47. Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 2013 Nov; 57(11):5619-28. PMID: 24002093; PMCID: PMC3811269.
      Citations:    
    48. Wolf J, Curtis N, Worth LJ, Flynn PM. Central line-associated bloodstream infection in children: an update on treatment. Pediatr Infect Dis J. 2013 Aug; 32(8):905-10. PMID: 23856714.
      Citations:    
    49. Pass RF, Nachman S, Flynn PM, Muresan P, Fenton T, Cunningham CK, Borkowsky W, McAuley JB, Spector SA, Petzold E, Levy W, Siberry GK, Handelsman E, Utech LJ, Weinberg A. Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth. J Pediatric Infect Dis Soc. 2013 Dec; 2(4):352-60. PMID: 24363932; PMCID: PMC3869470.
      Citations:    
    50. Bernardo VA, Cross SJ, Crews KR, Flynn PM, Hoffman JM, Knapp KM, Pauley JL, Molinelli AR, Greene WL. Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer. Ann Pharmacother. 2013 Jul-Aug; 47(7-8):976-83. PMID: 23737511; PMCID: PMC4384822.
      Citations:    
    51. Hoffman JM, Frediani J, Herr M, Flynn PM, Adderson EE. The safety of cefepime and ceftazidime in pediatric oncology patients. Pediatr Blood Cancer. 2013 May; 60(5):806-9. PMID: 23382054; PMCID: PMC4006133.
      Citations:    
    52. Weinberg A, Muresan P, Fenton T, Richardson K, Dominguez T, Bloom A, Petzold E, Anthony P, Cunningham CK, Spector SA, Nachman S, Siberry GK, Handelsman E, Flynn PM. High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088). Hum Vaccin Immunother. 2013 May; 9(5):957-68. PMID: 23370281; PMCID: PMC3899162.
      Citations:    
    53. Lee S, Kapogiannis BG, Flynn PM, Rudy BJ, Bethel J, Ahmad S, Tucker D, Abdalian SE, Hoffman D, Wilson CM, Cunningham CK. Comprehension of a simplified assent form in a vaccine trial for adolescents. J Med Ethics. 2013 Jun; 39(6):410-2. PMID: 23349510; PMCID: PMC3655100.
      Citations:    
    54. Minniear TD, Gaur AH, Thridandapani A, Sinnock C, Tolley EA, Flynn PM. Delayed entry into and failure to remain in HIV care among HIV-infected adolescents. AIDS Res Hum Retroviruses. 2013 Jan; 29(1):99-104. PMID: 23033848.
      Citations:    
    55. Gaur AH, Flynn PM, Bitar W, Liang H. Optimizing frequency of CD4 assays in the era of highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2013 Mar; 29(3):418-22. PMID: 23016543; PMCID: PMC3581070.
      Citations:    
    56. Srinivasan A, Flynn P, Gu Z, Hartford C, Lovins R, Sunkara A, Srivastava DK, Leung W, Hayden RT. Detection of respiratory viruses in asymptomatic children undergoing allogeneic hematopoietic cell transplantation. Pediatr Blood Cancer. 2013 Jan; 60(1):149-51. PMID: 22987475; PMCID: PMC3502722.
      Citations:    
    57. Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB. Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab. 2012 Nov; 97(11):4004-13. PMID: 22933542; PMCID: PMC3485594.
      Citations:    
    58. Wolf J, Shenep JL, Clifford V, Curtis N, Flynn PM. Ethanol lock therapy in pediatric hematology and oncology. Pediatr Blood Cancer. 2013 Jan; 60(1):18-25. PMID: 22911535.
      Citations:    
    59. Flynn PM, Nachman S, Muresan P, Fenton T, Spector SA, Cunningham CK, Pass R, Yogev R, Burchett S, Heckman B, Bloom A, Utech LJ, Anthony P, Petzold E, Levy W, Siberry GK, Ebiasah R, Miller J, Handelsman E, Weinberg A. Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults. J Infect Dis. 2012 Aug 01; 206(3):421-30. PMID: 22615311; PMCID: PMC3490699.
      Citations:    
    60. Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Mulligan K. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis. 2012 Apr; 54(7):1013-25. PMID: 22267714; PMCID: PMC3297650.
      Citations:    
    61. Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Vaccine. 2012 Jan 20; 30(5):879-85. PMID: 22155630.
      Citations:    
    62. Carr S, Allison KJ, Van De Velde LA, Zhang K, English EY, Iverson A, Daw NC, Howard SC, Navid F, Rodriguez-Galindo C, Yang J, Adderson EE, McCullers JA, Flynn PM. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. J Infect Dis. 2011 Nov 15; 204(10):1475-82. PMID: 21949042.
      Citations:    
    63. Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E, Cotter A, Purswani M. Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants. Antimicrob Agents Chemother. 2011 Dec; 55(12):5914-22. PMID: 21896911; PMCID: PMC3232794.
      Citations:    
    64. Flynn PM, Betancourt H, Ormseth SR. Culture, emotion, and cancer screening: an integrative framework for investigating health behavior. Ann Behav Med. 2011 Aug; 42(1):79-90. PMID: 21472484.
      Citations:    
    65. Halasa N, Englund JA, Nachman S, Weinberg GA, Huber VC, Allison K, Dubovsky F, Yi T, McCullers JA, Flynn PM. Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Vaccine. 2011 May 31; 29(24):4110-5. PMID: 21496468.
      Citations:    
    66. Flynn PM, Cunningham CK, Rudy B, Wilson CM, Kapogiannis B, Worrell C, Bethel J, Monte D, Bojan K. Hepatitis B vaccination in HIV-infected youth: a randomized trial of three regimens. J Acquir Immune Defic Syndr. 2011 Apr; 56(4):325-32. PMID: 21350366; PMCID: PMC3079288.
      Citations:    
    67. Betancourt H, Flynn PM, Ormseth SR. Healthcare mistreatment and continuity of cancer screening among Latino and Anglo American women in southern california. Women Health. 2011 Jan; 51(1):1-24. PMID: 21391158; PMCID: PMC3086030.
      Citations:    
    68. Garvie PA, Flynn PM, Belzer M, Britto P, Hu C, Graham B, Neely M, McSherry GD, Spector SA, Gaur AH. Psychological factors, beliefs about medication, and adherence of youth with human immunodeficiency virus in a multisite directly observed therapy pilot study. J Adolesc Health. 2011 Jun; 48(6):637-40. PMID: 21575827; PMCID: PMC3096841.
      Citations:    
    69. Betancourt H, Flynn PM, Riggs M, Garberoglio C. A cultural research approach to instrument development: the case of breast and cervical cancer screening among Latino and Anglo women. Health Educ Res. 2010 Dec; 25(6):991-1007. PMID: 20864605; PMCID: PMC2974838.
      Citations:    
    70. Gaur AH, Belzer M, Britto P, Garvie PA, Hu C, Graham B, Neely M, McSherry G, Spector SA, Flynn PM. Directly observed therapy (DOT) for nonadherent HIV-infected youth: lessons learned, challenges ahead. AIDS Res Hum Retroviruses. 2010 Sep; 26(9):947-53. PMID: 20707731; PMCID: PMC2957634.
      Citations:    
    71. Adderson EE, Flynn PM, Hoffman JM. Efficacy and safety of cefepime in pediatric patients: a systematic review and meta-analysis. J Pediatr. 2010 Sep; 157(3):490-5, 495.e1. PMID: 20434167.
      Citations:    
    72. Son M, Shapiro ED, LaRussa P, Neu N, Michalik DE, Meglin M, Jurgrau A, Bitar W, Vasquez M, Flynn P, Gershon AA. Effectiveness of varicella vaccine in children infected with HIV. J Infect Dis. 2010 Jun 15; 201(12):1806-10. PMID: 20441519; PMCID: PMC2871955.
      Citations:    
    73. Cunningham CK, Rudy BJ, Xu J, Bethel J, Kapogiannis BG, Ahmad S, Wilson CM, Flynn PM. Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States. Pediatr Infect Dis J. 2010 Jun; 29(6):530-4. PMID: 20173677; PMCID: PMC3274492.
      Citations:    
    74. McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM. Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus. Clin Infect Dis. 2010 Jun 01; 50(11):1487-92. PMID: 20415539; PMCID: PMC2946351.
      Citations:    
    75. Marón G, Gaur AH, Flynn PM. Antiretroviral therapy in HIV-infected infants and children. Pediatr Infect Dis J. 2010 Apr; 29(4):360-3. PMID: 20351530.
      Citations:    
    76. Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K. Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination. Vaccine. 2010 May 07; 28(21):3672-8. PMID: 20356567; PMCID: PMC2862082.
      Citations:    
    77. Henry-Reid LM, O'Connor KG, Klein JD, Cooper E, Flynn P, Futterman DC. Current pediatrician practices in identifying high-risk behaviors of adolescents. Pediatrics. 2010 Apr; 125(4):e741-7. PMID: 20308220.
      Citations:    
    78. Srinivasan A, Seifried S, Zhu L, Srivastava DK, Flynn PM, Bankowski MJ, Shenep JL, Hayden RT. Staphylococcus aureus bacteremia in pediatric patients with cancer. Pediatr Infect Dis J. 2010 Feb; 29(2):172-4. PMID: 19918212; PMCID: PMC4724395.
      Citations:    
    79. Brown SA, Surman SL, Sealy R, Jones BG, Slobod KS, Branum K, Lockey TD, Howlett N, Freiden P, Flynn P, Hurwitz JL. Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials. Viruses. 2010 Feb 01; 2(2):435-467. PMID: 20407589.
      Citations:    
    80. Hakim H, Flynn PM, Srivastava DK, Knapp KM, Li C, Okuma J, Gaur AH. Risk prediction in pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis J. 2010 Jan; 29(1):53-9. PMID: 19996816.
      Citations:    
    81. Gaur AH, Bagga B, Barman S, Hayden R, Lamptey A, Hoffman JM, Bhojwani D, Flynn PM, Tuomanen E, Webby R. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med. 2010 Jan 07; 362(1):88-9. PMID: 20032317.
      Citations:    
    82. Srinivasan A, Seifried S, Zhu L, Srivastava DK, Flynn PM, Shenep JL, Bankowski MJ, Hayden RT. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer. Pediatr Blood Cancer. 2009 Dec 15; 53(7):1216-20. PMID: 19731325; PMCID: PMC3075015.
      Citations:    
    83. Srinivasan A, Seifried S, Zhu L, Bitar W, Srivastava DK, Shenep JL, Bankowski MJ, Flynn PM, Hayden RT. Short communication: methicillin-resistant Staphylococcus aureus infections in children and young adults infected with HIV. AIDS Res Hum Retroviruses. 2009 Dec; 25(12):1219-24. PMID: 20001313; PMCID: PMC2858900.
      Citations:    
    84. Flynn PM. Diagnosis and management of central venous catheter-related bloodstream infections in pediatric patients. Pediatr Infect Dis J. 2009 Nov; 28(11):1016-7. PMID: 19859018.
      Citations:    
    85. Lindsey JC, Bosch RJ, Rudy BJ, Flynn PM. Early patterns of adherence in adolescents initiating highly active antiretroviral therapy predict long-term adherence, virologic, and immunologic control. AIDS Patient Care STDS. 2009 Oct; 23(10):799-801. PMID: 19803676; PMCID: PMC2832651.
      Citations:    
    86. Blanche S, Bologna R, Cahn P, Rugina S, Flynn P, Fortuny C, Vis P, Sekar V, van Baelen B, Dierynck I, Spinosa-Guzman S. Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents. AIDS. 2009 Sep 24; 23(15):2005-13. PMID: 19724191.
      Citations:    
    87. Minniear TD, Gilmore B, Arnold SR, Flynn PM, Knapp KM, Gaur AH. Implementation of and barriers to routine HIV screening for adolescents. Pediatrics. 2009 Oct; 124(4):1076-84. PMID: 19752084.
      Citations:    
    88. Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol. 2009 Sep; 31(9):623-9. PMID: 19644403; PMCID: PMC2743072.
      Citations:    
    89. Li Y, Ni R, Song W, Shao W, Shrestha S, Ahmad S, Cunningham CK, Flynn PM, Kapogiannis BG, Wilson CM, Tang J. Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum Genet. 2009 Nov; 126(5):685-96. PMID: 19597844; PMCID: PMC2771141.
      Citations:    
    90. Garcia KS, Flynn P, Pierce KJ, Caudle M. Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimul. 2010 Jan; 3(1):36-41. PMID: 20633429.
      Citations:    
    91. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Jul 01; 49(1):1-45. PMID: 19489710; PMCID: PMC4039170.
      Citations:    
    92. Sealy R, Slobod KS, Flynn P, Branum K, Surman S, Jones B, Freiden P, Lockey T, Howlett N, Hurwitz JL. Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine. Int Rev Immunol. 2009; 28(1):49-68. PMID: 19241253; PMCID: PMC2649747.
      Citations:    
    93. Garvie PA, Lawford J, Flynn PM, Gaur AH, Belzer M, McSherry GD, Hu C. Development of a directly observed therapy adherence intervention for adolescents with human immunodeficiency virus-1: application of focus group methodology to inform design, feasibility, and acceptability. J Adolesc Health. 2009 Feb; 44(2):124-32. PMID: 19167660; PMCID: PMC2659610.
      Citations:    
    94. Kurt B, Flynn P, Shenep JL, Pounds S, Lensing S, Ribeiro RC, Pui CH, Razzouk BI, Rubnitz JE. Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia. Cancer. 2008 Jul 15; 113(2):376-82. PMID: 18459178.
      Citations:    
    95. Agwu A, Lindsey JC, Ferguson K, Zhang H, Spector S, Rudy BJ, Ray SC, Douglas SD, Flynn PM, Persaud D. Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy. AIDS Patient Care STDS. 2008 Jul; 22(7):545-52. PMID: 18479228; PMCID: PMC2929158.
      Citations:    
    96. Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR, Harris DR, Havens PL. Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection. Antimicrob Agents Chemother. 2008 Feb; 52(2):631-7. PMID: 18025112; PMCID: PMC2224775.
      Citations:    
    97. Flynn PM, Rudy BJ, Lindsey JC, Douglas SD, Lathey J, Spector SA, Martinez J, Silio M, Belzer M, Friedman L, D'Angelo L, Smith E, Hodge J, Hughes MD. Long-term observation of adolescents initiating HAART therapy: three-year follow-up. AIDS Res Hum Retroviruses. 2007 Oct; 23(10):1208-14. PMID: 17961106.
      Citations:    
    98. Flynn PM, Rodman J, Lindsey JC, Robbins B, Capparelli E, Knapp KM, Rodriguez JF, McNamara J, Serchuck L, Heckman B, Martinez J. Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents. Antimicrob Agents Chemother. 2007 Oct; 51(10):3516-22. PMID: 17664328; PMCID: PMC2043291.
      Citations:    
    99. McKinney RE, Rodman J, Hu C, Britto P, Hughes M, Smith ME, Serchuck LK, Kraimer J, Ortiz AA, Flynn P, Yogev R, Spector S, Draper L, Tran P, Scites M, Dickover R, Weinberg A, Cunningham C, Abrams E, Blum MR, Chittick GE, Reynolds L, Rathore M. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021. Pediatrics. 2007 Aug; 120(2):e416-23. PMID: 17646352.
      Citations:    
    100. Hope WW, Seibel NL, Schwartz CL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ. Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing. Antimicrob Agents Chemother. 2007 Oct; 51(10):3714-9. PMID: 17638696; PMCID: PMC2043253.
      Citations:    
    101. Madden RM, Pui CH, Hughes WT, Flynn PM, Leung W. Prophylaxis of Pneumocystis carinii pneumonia with atovaquone in children with leukemia. Cancer. 2007 Apr 15; 109(8):1654-8. PMID: 17345613.
      Citations:    
    102. Flynn P, Havens P, Brady M, Emmanuel P, Read J, Hoyt L, Henry-Reid L, Van Dyke R, Mofenson L. Male circumcision for prevention of HIV and other sexually transmitted diseases. Pediatrics. 2007 Apr; 119(4):821-2. PMID: 17403855.
      Citations:    
    103. Zhou Z, Rodman JH, Flynn PM, Robbins BL, Wilcox CK, D'Argenio DZ. Model for intracellular Lamivudine metabolism in peripheral blood mononuclear cells ex vivo and in human immunodeficiency virus type 1-infected adolescents. Antimicrob Agents Chemother. 2006 Aug; 50(8):2686-94. PMID: 16870759; PMCID: PMC1538647.
      Citations:    
    104. Denning DW, Marr KA, Lau WM, Facklam DP, Ratanatharathorn V, Becker C, Ullmann AJ, Seibel NL, Flynn PM, van Burik JA, Buell DN, Patterson TF. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis. J Infect. 2006 Nov; 53(5):337-49. PMID: 16678903.
      Citations:    
    105. Rudy BJ, Lindsey JC, Flynn PM, Bosch RJ, Wilson CM, Hughes ME, Douglas SD. Immune reconstitution and predictors of virologic failure in adolescents infected through risk behaviors and initiating HAART: week 60 results from the PACTG 381 cohort. AIDS Res Hum Retroviruses. 2006 Mar; 22(3):213-21. PMID: 16545007.
      Citations:    
    106. Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Schwartz C, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA. Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents. Antimicrob Agents Chemother. 2005 Nov; 49(11):4536-45. PMID: 16251293; PMCID: PMC1280172.
      Citations:    
    107. Rutstein RM, Gebo KA, Flynn PM, Fleishman JA, Sharp VL, Siberry GK, Spector SA. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy. Med Care. 2005 Sep; 43(9 Suppl):III15-22. PMID: 16116305.
      Citations:    
    108. Rutstein RM, Gebo KA, Siberry GK, Flynn PM, Spector SA, Sharp VL, Fleishman JA. Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001. Med Care. 2005 Sep; 43(9 Suppl):III31-9. PMID: 16116307.
      Citations:    
    109. Chadwick EG, Rodman JH, Britto P, Powell C, Palumbo P, Luzuriaga K, Hughes M, Abrams EJ, Flynn PM, Borkowsky W, Yogev R. Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age. Pediatr Infect Dis J. 2005 Sep; 24(9):793-800. PMID: 16148846.
      Citations:    
    110. Miller ML, Obert CA, Gao G, Daw NC, Flynn P, Tuomanen E. Cephalosporin-resistant pneumococci and sickle cell disease. Emerg Infect Dis. 2005 Aug; 11(8):1192-6. PMID: 16102306; PMCID: PMC3320473.
      Citations:    
    111. Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, Keirns J, Lau WM, Facklam DP, Buell DN, Walsh TJ. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother. 2005 Aug; 49(8):3317-24. PMID: 16048942; PMCID: PMC1196271.
      Citations:    
    112. Knapp KM, Flynn PM. Newer treatments for fungal infections. J Support Oncol. 2005 Jul-Aug; 3(4):290-8. PMID: 16092600.
      Citations:    
    113. Gaur AH, Flynn PM, Heine DJ, Giannini MA, Shenep JL, Hayden RT. Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J. 2005 May; 24(5):445-9. PMID: 15876945.
      Citations:    
    114. Gaur AH, Flynn PM, Shenep JL. Optimum management of pediatric patients with fever and neutropenia. Indian J Pediatr. 2004 Sep; 71(9):825-35. PMID: 15448391.
      Citations:    
    115. Franklin JA, Gaur AH, Shenep JL, Hu XJ, Flynn PM. In situ diagnosis of central venous catheter-related bloodstream infection without peripheral blood culture. Pediatr Infect Dis J. 2004 Jul; 23(7):614-8. PMID: 15247598.
      Citations:    
    116. Flynn PM, Rudy BJ, Douglas SD, Lathey J, Spector SA, Martinez J, Silio M, Belzer M, Friedman L, D'Angelo L, McNamara J, Hodge J, Hughes MD, Lindsey JC. Virologic and immunologic outcomes after 24 weeks in HIV type 1-infected adolescents receiving highly active antiretroviral therapy. J Infect Dis. 2004 Jul 15; 190(2):271-9. PMID: 15216461.
      Citations:    
    117. McCarty ML, Wilson MW, Fleming JC, Thompson JW, Sandlund JT, Flynn PM, Knapp KM, Haik BG, Ribeiro RC. Manifestations of fungal cellulitis of the orbit in children with neutropenia and fever. Ophthal Plast Reconstr Surg. 2004 May; 20(3):217-23. PMID: 15167730.
      Citations:    
    118. Wu H, Lathey J, Ruan P, Douglas SD, Spector SA, Lindsey J, Hughes MD, Rudy BJ, Flynn PM. Relationship of plasma HIV-1 RNA dynamics to baseline factors and virological responses to highly active antiretroviral therapy in adolescents (aged 12-22 years) infected through high-risk behavior. J Infect Dis. 2004 Feb 15; 189(4):593-601. PMID: 14767811.
      Citations:    
    119. Wang LH, Wiznia AA, Rathore MH, Chittick GE, Bakshi SS, Emmanuel PJ, Flynn PM. Pharmacokinetics and safety of single oral doses of emtricitabine in human immunodeficiency virus-infected children. Antimicrob Agents Chemother. 2004 Jan; 48(1):183-91. PMID: 14693538; PMCID: PMC310155.
      Citations:    
    120. Flynn PM, Willis B, Gaur AH, Shenep JL. Catheter design influences recurrence of catheter-related bloodstream infection in children with cancer. J Clin Oncol. 2003 Sep 15; 21(18):3520-5. PMID: 12972529.
      Citations:    
    121. Franklin JA, McCormick J, Flynn PM. Retrospective study of the safety of caspofungin in immunocompromised pediatric patients. Pediatr Infect Dis J. 2003 Aug; 22(8):747-9. PMID: 12938676.
      Citations:    
    122. Gaur AH, Flynn PM, Giannini MA, Shenep JL, Hayden RT. Difference in time to detection: a simple method to differentiate catheter-related from non-catheter-related bloodstream infection in immunocompromised pediatric patients. Clin Infect Dis. 2003 Aug 15; 37(4):469-75. PMID: 12905129.
      Citations:    
    123. Gaur A, Giannini MA, Flynn PM, Boudreaux JW, Mestemacher MA, Shenep JL, Hayden RT. Optimizing blood culture practices in pediatric immunocompromised patients: evaluation of media types and blood culture volume. Pediatr Infect Dis J. 2003 Jun; 22(6):545-52. PMID: 12799512.
      Citations:    
    124. Stanford PD, Monte DA, Briggs FM, Flynn PM, Tanney M, Ellenberg JH, Clingan KL, Rogers AS. Recruitment and retention of adolescent participants in HIV research: findings from the REACH (Reaching for Excellence in Adolescent Care and Health) Project. J Adolesc Health. 2003 Mar; 32(3):192-203. PMID: 12606113.
      Citations:    
    125. Luján-Zilbermann J, Bitar W, Knapp K, Flynn P. Human immunodeficiency virus type 1 RNA polymerase chain reaction reasonably excludes infection in exposed infants. Pediatr Infect Dis J. 2003 Jan; 22(1):97-9. PMID: 12553306.
      Citations:    
    126. Starr SE, Fletcher CV, Spector SA, Brundage RC, Yong FH, Douglas SD, Flynn PM, Kline MW. Efavirenz liquid formulation in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002 Jul; 21(7):659-63. PMID: 12237599.
      Citations:    
    Flynn's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (464)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _